We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The American Medical Association (AMA) last week approved a proposal calling for HHS to establish a comprehensive registry for clinical trials conducted in the U.S. to ensure that all study results — positive and negative — are publicly available.
HHS named a new health information technology (IT) czar and detailed recent progress in its efforts to establish electronic medical records at a May health IT summit.
The American Medical Association (AMA) yesterday approved a proposal calling for HHS to establish a comprehensive registry for clinical trials conducted in the U.S. to ensure that all study results — positive and negative — are publicly available.
A bill overwhelmingly passed by the House to prohibit OTC sales of dozens of steroid precursors would require HHS to evaluate the risks of other dietary supplements that contain substances similar to those listed in the legislation.
An internal review of FDA employee records to determine possible conflicts of interest has not identified any additional approved outside activities of concern, acting FDA Commissioner Lester Crawford announced.
Senate Finance Committee Chairman Charles Grassley (R-Iowa) is alleging his investigation into allegations the FDA withheld information about a possible link between antidepressant use and suicide in children is being thwarted by FDA managers.
The Centers for Medicare & Medicaid Services (CMS) and the National Cancer Institute (NCI) announced they will collaborate to speed up the process for bringing new anticancer drugs to patients.
The federal government could have saved $650 million in fiscal 2002 had it adopted alternative methods for pricing two popular inhalation drugs whose costs are reimbursed through Medicare, the HHS’ Office of Inspector General (OIG) said in its semiannual report to Congress released earlier this week.
HHS said last week that nearly 3 million beneficiaries have signed on in the first four weeks of the Medicare discount drug card program’s operation, despite widespread reports that enrollment in the new program has been lower than anticipated.
Lower prices for drugs that had been promised through the new Medicare prescription drug cards have failed to materialize, according to a report prepared by Rep. Henry Waxman (D-Calif.).